|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0010101,
umls-concept:C0017262,
umls-concept:C0025545,
umls-concept:C0032207,
umls-concept:C0033325,
umls-concept:C0079419,
umls-concept:C0185117,
umls-concept:C0205179,
umls-concept:C0683598,
umls-concept:C2911684
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2004-7-13
|
|
pubmed:abstractText |
The molecular predictor for cisplatin sensitivity in advanced non-small cell lung cancer (NSCLC) is still an open question at present. The purpose of this study was to evaluate the relationship of the cisplatin sensitivity/prognosis with the expression of excision repair cross complement-1 (ERCC-1), metallothionein (MT), and p53 in the paraffin-embedded tissue of advanced non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1000-467X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
845-50
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15248926-Adolescent,
pubmed-meshheading:15248926-Adult,
pubmed-meshheading:15248926-Aged,
pubmed-meshheading:15248926-Antineoplastic Agents,
pubmed-meshheading:15248926-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15248926-Cisplatin,
pubmed-meshheading:15248926-DNA-Binding Proteins,
pubmed-meshheading:15248926-Drug Resistance, Neoplasm,
pubmed-meshheading:15248926-Endonucleases,
pubmed-meshheading:15248926-Female,
pubmed-meshheading:15248926-Humans,
pubmed-meshheading:15248926-Lung Neoplasms,
pubmed-meshheading:15248926-Male,
pubmed-meshheading:15248926-Metallothionein,
pubmed-meshheading:15248926-Middle Aged,
pubmed-meshheading:15248926-Neoplasm Staging,
pubmed-meshheading:15248926-Prognosis,
pubmed-meshheading:15248926-Proportional Hazards Models,
pubmed-meshheading:15248926-Survival Rate,
pubmed-meshheading:15248926-Tumor Suppressor Protein p53
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
[Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
|
|
pubmed:affiliation |
Department of Medical Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P.R.China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
